Robert Bain Thomas, Director at REVA Medical, Inc. (RVA.AX), bought 5,000 shares at $2.08 ($10K) on 2018-05-31, disclosed to the SEC on 2018-06-01.
Open-market purchase of $10k RVA.AX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.06 | 2,000 | $4K | 39.8% |
| 2 | $2.08 | 3,000 | $6K | 60.2% |
| Total | $2.07 avg | 5,000 | $10K | 100% |
| Filing → |
| RVA.AX | BUY | 2018-03-30 | $15K | — | Filing → |
| RVA.AX | BUY | 2018-03-28 | $15K | — | Filing → |
| RVA | BUY | 2016-07-19 | $224K | — | Filing → |